Marker Therapeutics, Inc. (MRKR)
1.40
-0.04
(-2.78%)
USD |
NASDAQ |
Mar 05, 13:49
Marker Therapeutics Free Cash Flow : -14.82M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ADMA Biologics, Inc. | 27.50M |
| Viridian Therapeutics, Inc. | -277.36M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Kiniksa Pharmaceuticals International Plc | 136.42M |
| Neurocrine Biosciences, Inc. | 748.70M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.736M |
| Cash from Financing (Quarterly) | 9.864M |
| Free Cash Flow Per Share (Quarterly) | -0.1633 |
| Free Cash Flow to Equity (Quarterly) | -2.736M |
| Free Cash Flow to Firm (Quarterly) | -2.736M |
| Free Cash Flow Yield | -83.14% |